MONDAY, March 16, 2020 -- Exercise benefits prostate cancer patients who undergo hormone-reducing therapy, a small study suggests.
The treatment -- called androgen suppression therapy or androgen deprivation therapy (ADT) -- uses drugs or surgery to reduce the level of androgen hormones, which prostate cancer cells typically require to multiply.
THURSDAY, Feb. 13, 2020 -- Young men who believe that "real men don't cry" may be more prone to suicide, a new study suggests.
It has long been known that men are more likely than women to end their own lives: In the United States, the suicide death rate among men is about 3.5 times that of women, according to the U.S. Centers for Disease Control and Prevention.
FRIDAY, Feb. 14, 2020 -- Drugs that many men with prostate cancer might already be taking -- cholesterol-lowering statins -- may help extend their survival if they have a "high-risk" form of the disease, new research suggests.
High-risk patients include men with high blood levels of prostate specific antigen (PSA) and a "Gleason score" of 8 or more. Gleason scores are a calculation used to gauge prognosis in prostate cancer. Men with a high Gleason score may develop difficult-to-treat cancers.